Clinical Trials Directory

Trials / Completed

CompletedNCT01245972

Pilot Study of PDL to Treat BCC and SCCIS

A Pilot Study to Examine the Effectiveness of 595nM Pulsed Dye Lasers in the Treatment of Basal Cell Carcinoma and Squamous Cell Carcinoma in Situ

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a research study to find out more about the use of the pulsed dye laser in the treatment of basal cell carcinoma and early stage squamous cell carcinoma that has not invaded deep into the skin. The purpose of this study is to determine whether the use of the pulsed dye laser (PDL) can completely clear or regress basal cell carcinoma or early stage squamous cell carcinoma. Pulsed dye laser is a type of laser that is commonly used to treat lesions on the skin that have a prominent blood vessel component. It has been used to treat broken blood vessels on the face, hemangiomas in children and adults, leg veins, port wine stains, and other lesions with a prominent vascular component.

Conditions

Interventions

TypeNameDescription
PROCEDUREPDL TreatmentPulsed-dye laser (PDL) treatment at one of two settings.

Timeline

Start date
2010-08-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2010-11-23
Last updated
2019-09-16
Results posted
2019-09-16

Source: ClinicalTrials.gov record NCT01245972. Inclusion in this directory is not an endorsement.